Characteristics | Inflammation—low (IS < 15, n = 33) | Inflammation—high (IS ≥ 15, n = 43) | P value |
---|---|---|---|
Catecholamine levelsa (pmol/L) | Â | Â | Â |
 Epi | 1131.5 (656.0–1901.9) | 1655.0 (733.2–4307.4) | 0.110 |
 NE | 6064.3 (3081.0–18373.4) | 12,110.0* (7653.1–37,939.8) | 0.013 |
Injury severity | Â | Â | Â |
 GCS | 7.0 (4.0–9.0) | 3.0* (3.0–7.0) | 0.002 |
 AIS head | 4.0 (3.0–5.0) | 5.0* (4.0–5.0) | 0.006 |
 ISS | 20.5 (16.5–29.5) | 29.5* (20.0–35.0) | 0.014 |
Outcome (n) | Â | Â | Â |
 Sepsis/infection | 13 | 9 | 0.079 |
 Unfavorable 6-month GOSE | 14 | 33* | 0.002 |
 Overall mortality | 4 | 16* | 0.014 |
 Neurologic death | 2 | 13* | 0.009 |